Market closed

Inspire Medical Systems/$INSP

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Inspire Medical Systems

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Ticker

$INSP
Sector
Health Care

Trading on

NYSE

Industry

Health Care Equipment & Supplies
Headquarters
Golden Valley, United States

Employees

1,011
Website
www.inspiresleep.com

INSP Metrics

BasicAdvanced
$5.3B
160.42
$1.09
1.36
-

$5.3B

1.36

$257.40

$123.00

524K

7.844

6.743

3.62

3.636

1.18%

5.33%

160.425

6.892

7.55

7.55

136.321

32.52%

-197.20%

55.49%

-14.32%

What the Analysts think about INSP

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Inspire Medical Systems stock.

INSP Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

INSP Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

INSP News

AllArticlesVideos
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2024 and Provides Initial 2025 Revenue Guidance

Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2024 and Provides Initial 2025 Revenue Guidance

GlobeNewsWire·2 days ago
Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference

Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewsWire·2 weeks ago
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Investopedia·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $INSP

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Inspire Medical Systems stock?

Inspire Medical Systems (INSP) has a market cap of $5.3B as of January 15, 2025.

What is the P/E ratio for Inspire Medical Systems stock?

The price to earnings (P/E) ratio for Inspire Medical Systems (INSP) stock is 160.42 as of January 15, 2025.

Does Inspire Medical Systems stock pay dividends?

No, Inspire Medical Systems (INSP) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Inspire Medical Systems dividend payment date?

Inspire Medical Systems (INSP) stock does not pay dividends to its shareholders.

What is the beta indicator for Inspire Medical Systems?

Inspire Medical Systems (INSP) has a beta rating of 1.36. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.